ABSTRACT
Male hypogonadism is a multisystem clinical syndrome that results from subphysiological circulating levels of testosterone because of disruption of one or more levels of the hypothalamic-pituitary-testicular (HPT) axis (1). Defective androgen receptor (AR) or specific converting enzymes at target organs also results in hypogonadism.
